QuickOpt Chronic Study
Clinical Impact of Cardiac Resynchronization Therapy on Heart Failure Patients With QuickOpt and Echo Optimization
1 other identifier
interventional
400
1 country
1
Brief Summary
The purpose of this study is to demonstrate that QuickOpt optimization can be as an alternative method for CRTP/D patients' optimization in clinical practice through the comparison of the improvement differences between the CRTP/D patients with different optimization at 12 months after implantation.The hypothesis is that the Heart Remolding parameter (LVESV) improvement of patients using QuickOpt parameters at 12 months after implant is not inferior (10%) to the patients by Echo optimization。
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable heart-failure
Started May 2010
Longer than P75 for not_applicable heart-failure
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2010
CompletedFirst Submitted
Initial submission to the registry
July 28, 2010
CompletedFirst Posted
Study publicly available on registry
July 29, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2016
CompletedResults Posted
Study results publicly available
September 30, 2019
CompletedOctober 8, 2019
September 1, 2019
5.6 years
July 28, 2010
May 29, 2019
September 27, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percent Change in Left Ventricular End Systolic Volume (LVESV) at 12 Months Compared to Baseline
The primary outcome is the percent change in LVESV at 12 months compared to baseline. This outcome measure is assessed through evaluation of echocardiograms at both baseline and 12 months, with a decrease in the percent change in LVESV at 12 months indicating clinical improvement. The percent change in patients with devices optimized with QuickOpt is compared with that of patients with devices optimized using standard echocardiography techniques to determine if one method of optimization results in a greater change in LVESV.
Baseline and12 months
Study Arms (2)
Quickopt Group
EXPERIMENTALthe QuickOpt Group patients will be optimized by QuickOpt(IEGM);
Echocardiography group
ACTIVE COMPARATORthe Echo Group patients will be optimized by Echo.
Interventions
Patients will be optimized using QuickOpt (IEGM) algorithm installed on the Merlin device programmer within 2 weeks and 3 and 6 months after device implantation.
Optimization of the AV/PV and VV delays using echocardiography
Eligibility Criteria
You may qualify if:
- Patient meets current CRT-P indications and be implanted with an SJM CRT-P device with V-V timing and a compatible lead system
- Patient is able to provide written informed consent for study participation
You may not qualify if:
- Patient has limited intrinsic atrial activity (≤ 40 bpm)
- Patient has persistent or permanent AF
- Patient has a 2o or 3o heart block
- Patient's life expectancy is \<12 months
- Patient is \<18 years old
- Patient is pregnant
- Patient is on IV inotropic agents
- Patients who are ongoing other devices or agents study
- Patients with heart transplanted or waiting for heart transplant
- Patients with Hypertrophic and obstructive cardiomyopathy
- Patients with severe aortic valve and mitral valve stenosis or regurgitation without replacement
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fuwai Hospital
Beijing, Beijing Municipality, 100037, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Clay Cohorn, Program Director
- Organization
- CRT, Global Clinical Affairs, Cardiac Arrhythmias and Heart Failure, Abbott Medical Devices
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 28, 2010
First Posted
July 29, 2010
Study Start
May 1, 2010
Primary Completion
December 1, 2015
Study Completion
January 1, 2016
Last Updated
October 8, 2019
Results First Posted
September 30, 2019
Record last verified: 2019-09